NPI registry status
Active
2026 NPPES data Neuro-ophthalmology Physician NPI 1619397635 M.D.
Verify on CMS → Robert Levy, M.D.
Neuro-ophthalmology Physician in Chattanooga, Tennessee.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 139 in Neuro-ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 747 beneficiaries · Neuro-ophthalmology Physician avg: 487
Generic prescribing
79%
generic claims · 21% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$559.36
25 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Robert Levy, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,955 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 2K
- Part D claims, 2024
- 79%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Robert Levy, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1619397635), first enumerated 04/17/2014.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,955 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$559.36 in reported industry payments (25 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1619397635 · Neuro-ophthalmology Physician
NPI-10 · ENUM-MID · TAX-TRACE · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1619397635
- ENUM-MID 2014
- TAX-TRACE 139
- MIPS-NEUTRAL 75/100
- RX-MID 1,955
- BOOK-THIN 1 in Tennessee
- PHOTO-ENUM Leanne Stunkel, MD · 2014
Robert Levy, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,955 ≥ 83rd percentile 83% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Robert Levy, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Robert Levy, M.D.?
CMS neutral score, not measuredPrimary specialty
Neuro-ophthalmology Physician
Medicare Part D claims
1,955 301% vs specialty avg
MIPS final score
75/100
Specialty distribution in Tennessee
How Neuro-ophthalmology Physician compares to other specialties among Tennessee providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1619397635 |
|---|---|
| Specialty | Neuro-ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/17/2014 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Hospital and facility affiliations
Facilities where Robert Levy, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Chattanooga Eye Institute,p.c.
Chattanooga, TN
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Robert Levy, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$559
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Robert Levy, M.D. - brand share 21.0%
Neuro-ophthalmology Physician average
21% brand-name claims vs 79% generic, on 1,955 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,955
Total Claims
$154K
Total Drug Cost
747
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,695.967
- Total Day Supply
- 56,651
- Brand vs Generic
- 21% brand / 79% generic
- Brand Drug Cost
- $129K
- Generic Drug Cost
- $25K
- Opioid Claims
- 365 (18.7% rate)
- Antibiotic Claims
- 114
Patient Demographics
- Average Patient Age
- 75.3 years
- Avg HCC Risk Score
- 1.28
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 44, 65-74: 295, 75-84: 314, 85+: 94
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Robert Levy, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Erythromycin
Erythromycin
405 claims
- Latanoprost
Latanoprost
290 claims
- Tramadol Hcl
Tramadol Hcl
237 claims
- Oxycodone-Acetamin… 126
Oxycodone-Acetaminophen
126 claims
- Fluorometholone 96
Fluorometholone
96 claims
- Doxycycline Hyclate 89
Doxycycline Hyclate
89 claims
- Tobramycin-Dexamet… 73
Tobramycin-Dexamethasone
73 claims
- Restasis 69
Restasis
69 claims
| Drug | Claims |
|---|---|
| Erythromycin Erythromycin Base | 405 |
| Latanoprost | 290 |
| Tramadol Hcl | 237 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 126 |
| Fluorometholone | 96 |
| Doxycycline Hyclate | 89 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 73 |
| Restasis Cyclosporine | 69 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 67 |
| Lumigan Bimatoprost | 50 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neuro-ophthalmology Physician Overview
How Robert Levy, M.D. fits within the Neuro-ophthalmology Physician landscape nationally.
139
Neuro-ophthalmology Physician Providers in US
33
States with Neuro-ophthalmology Physician
487
Avg Claims per Provider
Robert Levy, M.D.'s 1,955 claims are above the specialty average of 487.
Nationwide Neuro-ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Levy, both outside Tennessee so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2014)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Frequently Asked Questions
What is Robert Levy, M.D.'s specialty? ▼
Robert Levy, M.D. specializes in Neuro-ophthalmology Physician and practices in Chattanooga, Tennessee. Credentials: M.D..
How much does Robert Levy, M.D. prescribe under Medicare Part D? ▼
In 2024, Robert Levy, M.D. wrote 1,955 Medicare Part D claims totaling $154K in drug costs for 747 beneficiaries.
What is Robert Levy, M.D.'s Medicare quality score? ▼
Robert Levy, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Robert Levy, M.D. located? ▼
Robert Levy, M.D. is located at 5715 CORNELISON RD, Chattanooga, TN, 37411. Phone: (423) 892-3937.
What is Robert Levy, M.D.'s NPI number? ▼
Robert Levy, M.D.'s National Provider Identifier (NPI) is 1619397635, issued on 04/17/2014.
Does Robert Levy, M.D. prescribe more brand-name or generic drugs? ▼
Robert Levy, M.D.'s prescribing is 21% brand-name and 79% generic drugs by claim count, with $129K in brand drug costs.
Does Robert Levy, M.D. prescribe opioids? ▼
Yes, Robert Levy, M.D. had 365 opioid claims in 2024 with an opioid prescribing rate of 18.7%.
How many Neuro-ophthalmology Physician providers are there in the US? ▼
There are 139 Neuro-ophthalmology Physician providers across 33 states in the US. The average Neuro-ophthalmology Physician provider writes 487 Medicare Part D claims per year.
What drugs does Robert Levy, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Robert Levy, M.D.'s most frequently prescribed drugs include Erythromycin, Latanoprost, Tramadol Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Robert Levy, M.D. accept Medicare? ▼
Robert Levy, M.D. appears in CMS Medicare data with 1,955 Part D claims and 747 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Robert Levy, M.D.'s credentials? ▼
Robert Levy, M.D.'s NPI is 1619397635 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.